Brain stimulation with mental training games for lingering Lyme disease brain fog
Tests gentle brain stimulation plus thinking games in people with post-treatment Lyme disease.
Key facts
- Who runs it
- Columbia University
- Where
- New York and San Francisco, United StatesSee the 2 sites
- Trial code
- Registry title
- Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
- Status
- Recruiting
- People taking part
- 110 people, planned
- Started
- 14 Jul 2025
- Expected to end
- Aug 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Transcranial Direct Current Stimulation (tDCS)
- Cognitive training
- Record updated
- 6 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with thinking problems, like brain fog and slowed thinking speed, that stayed or came back after antibiotic treatment for Lyme disease. People will do computer brain-training games at home with real or inactive (sham) weak brain stimulation.
- Age
- 18 to 70 years
- Sex
- All sexes
- Disease stage
- Diagnosis of definite, probable or possible Lyme disease by a health care provider. Thinking symptoms that persisted or returned despite antibiotics and that affect daily life or cause distress.
- Earlier treatment
- At least 2 courses of antibiotics for Lyme disease. No antibiotics for tick-borne disease for at least 4 weeks before final eligibility check and during the 12-week study. Daily medicines stable for at least 4 weeks.
- Biomarker or test result
- Slowed processing speed on a screening test. Estimated intellectual ability >= 85.
Main reasons for not taking part
- Unstable other long-term illness in the last 12 months, severe skin problems near the forehead, or devices or metal implants in the head or neck
- Seizures, brain injury with lasting symptoms, head surgery, or moderate to severe headaches or migraines in the last month
- Current suicide risk, suicidal behavior in the last year, psychosis, mania, bipolar disorder, or moderate or severe depression
- Current alcohol or drug use disorder, or taking opiate-based or dissociative drugs
- Pregnant, breastfeeding or planning pregnancy
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- History of diagnosis of Lyme disease by a health care provider, meeting criteria for either definite or probable or possible LD
- Willingness to provide documentation of prior LD testing and/or related medical records
- Total prior antibiotic treatment for LD was at least 2 courses of antibiotic therapy
- Have cognitive symptoms attributed to Lyme disease that have persisted or returned despite antibiotic therapy
- Current cognitive symptoms interfere with function and/or cause distress
- Have evidence of slowed processing speed on a screening measure
- Participant is willing to be off of antibiotic treatment for tick-borne disease for at least 4 weeks prior to final determination of study eligibility and for the duration of the 12-week study
- Participant expresses willingness to not start new medications that might affect treatment outcome during the trial (unless medically necessary), and willingness to inform study staff regarding any changes in medication
- Live in the US or Canada and comfortable speaking English
- Age 18-70
- Stable and continuous access to internet service
- Adequate home facilities (enough space, access to quiet and distraction free area)
- Able to commit to the 12-week study period (4 weeks of training sessions and an 8-week post treatment visit)
- Estimated intellectual ability >= 85
Who cannot take part
- Depression rating of moderate or severe at screening; Currently taking opiate-based medications, dissociative drugs (prescribed or illicit), or other medication considered likely to interfere with treatment outcome at the discretion of the investigator. The use of a stable dose of benzodiazepines, anticholinergic agents and non-narcotic pain medications is permitted. The use of an occasional dose of these medications is also permitted, but not within 48 hours of neurocognitive study assessments; Participants whose current daily medication regimen has not been stable for a minimum of 4 weeks prior to final determination of study eligibility; Medical device implanted in the head (such as a Deep Brain Stimulator) or in the neck (such as a Vagus Nerve Stimulator), or metal implants in the head or neck; Inadequate visual or motor skills needed for regular computer use or to operate study equipment, or inability to provide informed consent; Individuals who are pregnant or breastfeeding or planning to become pregnant; Lifestyle Considerations: Participants not willing to refrain from beginning, resuming or increasing non study cognitive training or cognitive enhancing supplements/medications or other therapies that might affect treatment outcome
- Medical Illness: Any of the following: a. Unstable non-Lyme-related chronic medical illness over the last 12 months (e.g., cancer, acute myocardial infarction, labile hypertension) b. Any severe skin disorder or skin sensitive area near stimulation locations (e.g. forehead); Neurologic: Any of the following:
- History of traumatic brain injury with persistent post-concussive symptoms
- History of neurosurgery to the head
- Post stroke deficits that may interfere with assessment
- Any progressive neurodegenerative disorder or other neurological disorders that may interfere with assessment at discretion of the investigator; Psychiatric: Any of the following:
- History of intellectual disability, or other developmental neurological condition associated with cognitive impairment
- Current primary psychiatric disorder that would interfere with ability to participate
- Current alcohol or other substance use disorder
- History of suicidal behavior over the last year
- History of a diagnosis of a psychotic disorder, mania or bipolar disorder
- History of seizure disorder or recent (<5 years) seizure history
- Chronic headaches or migraines of moderate to severe intensity within the last month
- Current suicide risk as assessed by the C-SSRS (any level)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- Columbia University Department of PsychiatryNew York, United StatesContact: Alex Wetmore, BATaking people
- University of California San FranciscoSan Francisco, United StatesContact: Piper Chase, BATaking people
About the trial
What the trial wants to find out
The primary purpose of this pilot study is to investigate a novel approach to the treatment of cognitive symptoms that persist despite prior antibiotic treatment for Lyme disease (Post treatment Lyme Disease or PTLD).
Read full original descriptionShow less
Aim 1: The primary aim of this study is to assess whether the processing speed of individuals with PTLD can be enhanced by combining transcranial direct current stimulation (tDCS) with computer based cognitive training games. To achieve this aim, over a 4-week period, all individuals with PTLD will participate in at home adaptive cognitive training combined with either active stimulation or sham stimulation.
Aim 2: To determine if treatment benefit in processing speed is sustained, the study will compare the sham and active groups 8 weeks after completion of study treatment.
The 2 groups in the trial
- Cognitive training and active tDCSTreatment being tested
The cognitive training and brain stimulation sessions are conducted at home at the same time over 30 minutes, 5 days/week, for 4 weeks for a total of 20 sessions. Transcranial direct current stimulation (tDCS) is delivered by a user-friendly device; the participant wears a head-band that allows delivery of a weak electrical current (2mA) through two electrode patches over the forehead. The active stimulation session lasts 30 minutes. The cognitive training tasks are administered via a computer-based program BrainHQ (Posit Science). The BrainHQ adaptive cognitive training tasks have been previously associated with improved processing speed in other populations.
Treatment: Transcranial Direct Current Stimulation (tDCS) and Cognitive training
- Cognitive training and sham tDCSSham treatment, for comparison
The cognitive training and brain stimulation sessions are conducted at home at the same time over 30 minutes, 5 days/week, for 4 weeks for a total of 20 sessions. Transcranial direct current stimulation (tDCS) is delivered by a user-friendly device; the participant wears a head-band that allows delivery of a weak electrical current (2mA) through two electrode patches over the forehead. The inactive (sham) stimulation session lasts 30 minutes. The cognitive training tasks are administered via a computer-based program BrainHQ (Posit Science). The BrainHQ adaptive cognitive training tasks have been previously associated with improved processing speed in other populations.
Treatment: Transcranial Direct Current Stimulation (tDCS) and Cognitive training
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transcranial Direct Current Stimulation (tDCS) of Brain Fog in Patients With Post Treatment Lyme Disease
- Plain-language title
- Brain stimulation with mental training games for lingering Lyme disease brain fogGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06915324, who can take part
- Record updated
- 6 May 2026